GHIGO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 7.261
EU - Europa 4.539
AS - Asia 4.124
SA - Sud America 664
AF - Africa 107
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.748
Nazione #
US - Stati Uniti d'America 7.106
CN - Cina 1.653
SG - Singapore 1.526
DK - Danimarca 1.338
IT - Italia 946
BR - Brasile 537
DE - Germania 456
IE - Irlanda 352
SE - Svezia 244
FR - Francia 220
FI - Finlandia 187
VN - Vietnam 181
KR - Corea 145
GB - Regno Unito 132
UA - Ucraina 130
JP - Giappone 125
HK - Hong Kong 124
AT - Austria 109
IN - India 104
CA - Canada 100
BE - Belgio 81
PL - Polonia 78
PT - Portogallo 67
CH - Svizzera 48
AR - Argentina 47
AU - Australia 45
ID - Indonesia 38
NL - Olanda 36
MX - Messico 35
RU - Federazione Russa 34
BD - Bangladesh 31
TW - Taiwan 30
ES - Italia 29
IR - Iran 25
TR - Turchia 25
ZA - Sudafrica 23
IQ - Iraq 21
CO - Colombia 17
EC - Ecuador 17
SN - Senegal 17
PK - Pakistan 15
TH - Thailandia 12
EG - Egitto 11
NO - Norvegia 11
ET - Etiopia 10
MA - Marocco 10
NG - Nigeria 10
VE - Venezuela 10
CL - Cile 9
CZ - Repubblica Ceca 9
UY - Uruguay 9
IL - Israele 7
JO - Giordania 7
PE - Perù 7
BO - Bolivia 6
DZ - Algeria 6
UZ - Uzbekistan 6
EU - Europa 5
MY - Malesia 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
GR - Grecia 4
KE - Kenya 4
LB - Libano 4
LT - Lituania 4
PY - Paraguay 4
RO - Romania 4
SA - Arabia Saudita 4
SI - Slovenia 4
BW - Botswana 3
BY - Bielorussia 3
CR - Costa Rica 3
HU - Ungheria 3
KH - Cambogia 3
KZ - Kazakistan 3
MO - Macao, regione amministrativa speciale della Cina 3
OM - Oman 3
AL - Albania 2
BB - Barbados 2
BZ - Belize 2
GH - Ghana 2
GT - Guatemala 2
KG - Kirghizistan 2
LV - Lettonia 2
MU - Mauritius 2
PS - Palestinian Territory 2
RS - Serbia 2
TN - Tunisia 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GF - Guiana Francese 1
Totale 16.731
Città #
Ann Arbor 1.595
Singapore 825
Chandler 676
Ashburn 548
Santa Clara 494
Beijing 414
Dublin 351
Torino 255
Houston 245
Shenyang 221
Wilmington 211
Turin 166
Fairfield 159
Dallas 148
Munich 138
Nyköping 137
Columbus 121
Dearborn 112
Los Angeles 112
Hong Kong 95
Villeurbanne 93
Vienna 92
Seoul 87
Medford 86
Princeton 86
The Dalles 83
Boston 79
Guangzhou 79
Seattle 75
Jacksonville 74
Hefei 69
Milan 64
Buffalo 63
Redwood City 60
Hangzhou 57
Woodbridge 52
Helsinki 50
Warsaw 49
Ho Chi Minh City 47
Turku 42
Chennai 40
New York 40
Nuremberg 39
Shanghai 36
Tokyo 36
Cambridge 35
Nanjing 34
São Paulo 33
Pisa 32
Hanoi 30
Fremont 29
Grafing 29
Montréal 29
Redondo Beach 27
Frankfurt am Main 26
Jakarta 26
Rome 26
Palaiseau 25
Asti 23
Brussels 23
Fortaleza 23
Rio de Janeiro 23
Lappeenranta 21
Wuhan 21
Dong Ket 20
Maasmechelen 20
Chengdu 19
Chicago 19
London 18
Montreal 18
Phoenix 18
Verona 18
Zhengzhou 18
Bengaluru 17
Boardman 17
Campinas 17
San Diego 17
Hebei 16
Atlanta 15
Baltimore 15
Brooklyn 15
Falls Church 15
Taipei 15
Pittsburgh 14
Curitiba 13
Evanston 13
Hasselt 13
Mexico City 13
Toronto 13
Belo Horizonte 12
Castellana Grotte 12
Copenhagen 12
Tianjin 12
Tucson 12
Berlin 11
Brisbane 11
Chongqing 11
Guiyang 11
Kunming 11
Sydney 11
Totale 9.648
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 832
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 807
Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases 630
Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress 585
Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting 384
Distinct Effects of Leukocyte and Cardiac Phosphoinositide 3-Kinase {gamma} Activity in Pressure Overload-Induced Cardiac Failure 358
Pulmonary-derived phosphoinositide 3-kinase gamma (PI3Kγ) contributes to ventilator-induced lung injury and edema. 294
Integrating Cardiac PIP(3) and cAMP Signaling through a PKA Anchoring Function of p110γ. 284
Identification of the macromolecular complex responsible for PI3Kgamma-dependent regulation of cAMP levels. 283
Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases. 283
Contractile Function during Angiotensin-II Activation: Increased Nox2 Activity Modulates Cardiac Calcium Handling via Phospholamban Phosphorylation 280
Myocyte signalling in leucocyte recruitment to the heart. 276
Crossroads of PI3K and Rac pathways 271
Anchoring proteins as regulators of signaling pathways. 269
Ablation of Calcineurin Aβ Reveals Hyperlipidemia and Signaling Cross-talks with Phosphodiesterases. 266
Therapeutic applications of PI3K inhibitors in cardiovascular diseases. 263
Lack of kinase-independent activity of PI3Kγ in locus coeruleus induces ADHD symptoms through increased CREB signaling 258
Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits 257
PI3K in cancer-stroma interactions: bad in seed and ugly in soil. 256
Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease 255
NADPH Oxidases in Heart Failure: Poachers or Gamekeepers? 252
Specific PI3K Isoform Modulation in Heart Failure: Lessons from Transgenic Mice. 249
Taming the PI3K team to hold inflammation and cancer at bay 248
PI3K inhibition in inflammation:Toward tailored therapies for specific diseases 239
Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity 234
Phosphoinositide 3-kinases in health and disease. 233
Hyperactivity of Rac1-GTPase pathway impairs neuritogenesis of cortical neurons by altering actin dynamics 232
Hyper-activation of the Rho-GTPase Rac1 via disruption of ArhGAP15 results in reduced architectural and functional complexity 229
Phosphoinositides and cardiovascular diseases. 219
Elastin degradation and ensuing inflammation as emerging keys to atherosclerosis. 219
Metabolic Aspects of Anthracycline Cardiotoxicity 219
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 211
Isoform Selective Phosphoinositide 3-Kinase gamma and delta Inhibitors and Their Therapeutic Potential 206
Molecular mechanism of action of Pelargonidin-3-O-glucoside, the main anthocyanin responsible for the anti-inflammatory effect of strawberry fruits 205
Data demonstrating the anti-oxidant role of hemopexin in the heart 202
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 200
Antineoplastic drug-induced cardiotoxicity: A redox perspective 192
null 186
Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF) 170
Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis 139
Dysfunctional inflammation in cystic fibrosis airways: From mechanisms to novel therapeutic approaches 134
Pi3k signaling in chronic obstructive pulmonary disease: Mechanisms, targets, and therapy 126
Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure 120
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 120
Rac signal adaptation controls neutrophil mobilization from the bone marrow 116
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis 116
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 114
An intrinsic mechanism of metabolic tuning promotes cardiac resilience to stress 112
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 108
Cardiac dysfunction in cancer patients: Beyond direct cardiomyocyte damage of anticancer drugs: Novel cardio-oncology insights from the joint 2019 meeting of the ESC working groups of myocardial function and cellular biology of the heart 107
PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation 106
An integrated approach to cardioprotection in lymphomas 106
Tregs restrain dendritic cell autophagy to ameliorate autoimmunity 103
New signal transduction paradigms in anthracycline-induced cardiotoxicity 99
Signaling pathways underlying anthracycline cardiotoxicity 99
Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities 98
Phosphoinositide 3-kinase: friend and foe in cardiovascular disease 97
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs 96
Potential therapeutic applications of AKAP disrupting peptides 96
Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives 96
Mechanisms underlying the cross-talk between heart and cancer 95
PI3Ks in Diabetic Cardiomyopathy 94
A novel protective role for activating transcription factor 3 in the cardiac response to metabolic stress 92
PI3K and Calcium Signaling in Cardiovascular Disease 92
Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapy 91
cAMP/PKA signaling compartmentalization in cardiomyocytes: Lessons from FRET-based biosensors 88
Preventing and Treating Anthracycline Cardiotoxicity: New Insights 88
The human fetal and adult stem cell secretome can exert cardioprotective paracrine effects against cardiotoxicity and oxidative stress from cancer treatment 88
Inhaled Biologicals for the Treatment of Cystic Fibrosis 87
'Circulating' RNA-based therapies in Cardio-Oncology 86
Duality of Nrf2 in iron-overload cardiomyopathy 85
Combined inhibition of PI3Kβ and PI3Kγ reduces fat mass by enhancing α-MSH-dependent sympathetic drive. 85
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 85
Role of Protein Kinase A-Mediated Phosphorylation in CFTR Channel Activity Regulation 83
A nonnatural peptide targeting the A-kinase anchoring function of PI3Kγ for therapeutic cAMP modulation in pulmonary cells 81
Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons 80
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity 79
Cell-specific roles of p110β in myocardial ischemia 78
A non-catalytic function of PI3Kγ drives smooth muscle cell proliferation after arterial damage 78
Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice 77
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer? 77
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development 77
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury 75
Response by Vandecasteele et al to Letter Regarding Article, âCardiac Overexpression of PDE4B Blunts Î-Adrenergic Response and Maladaptive Remodeling in Heart Failureâ 74
Oxidative stress in anticancer therapies-related cardiac dysfunction 74
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia 74
17(R)-RESOLVIN D1 PROTECTS AGAINST SICKLE CELL-RELATED INFLAMMATORY CARDIOMYOPATHY IN HUMANIZED MICE 68
New avenues in cardio-oncology 66
Leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure. 63
It Takes Two to Tango! Protein–Protein Interactions behind cAMP-Mediated CFTR Regulation 62
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation 62
Extracellular vesicles derived from human livers stem cells counteract chronic kidney disease development and cardiac dysfunction in remnant kidney murine model: the possible involvement of proteases 61
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases 60
A nonnatural peptide targeting the A-kinase anchoring function of PI3Kg for therapeutic cAMP modulation in pulmonary cells 57
Roles of phosphatidyl inositol 3 kinase gamma (PI3Kγ) in respiratory diseases 57
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 56
Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide 55
Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association 54
Pi3k as mediator of apoptosis and contractile dysfunction in tgfβ1-stimulated cardiomyocytes 50
Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation? 49
Totale 16.827
Categoria #
all - tutte 49.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021708 0 0 0 0 0 43 116 25 139 81 58 246
2021/20222.361 236 231 197 243 192 191 176 172 143 103 240 237
2022/20232.161 184 183 75 203 176 474 145 135 252 69 123 142
2023/20241.265 157 170 126 86 94 94 87 92 26 135 69 129
2024/20253.541 78 408 107 231 723 302 179 177 316 234 314 472
2025/20262.693 632 281 389 599 557 235 0 0 0 0 0 0
Totale 17.224